Molecular pathogenesis of Marfan syndrome. (6th May 2015)

• Record Type: Journal Article
• Authors: Ramachandra, Chrishan J.A.; Mehta, Ashish; Guo, Kenneth Wei Qiang; Wong, Philip; Tan, Ju Le; Shim, Winston
• Is Part Of: International journal of cardiology. Volume 187(2015)
• Page Start: 585
• Page End: 591
• Publication Date: 2015-05-06
• Subjects: Marfan syndrome -- Fibrillin-1 -- TGF-β -- Aortic aneurysms -- Induced pluripotent stem cells; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2015.03.423
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Marfan syndrome (MFS) is a genetic disorder that affects multiple organs. Mortality imposed by aortic aneurysm and dissections represent the most serious clinical manifestation of MFS. Progressive pathological aortic root enlargement as the result of degeneration of microfibril architecture and consequential loss of extracellular matrix integrity due to fibrillin-1 ( FBN1 ) mutations are commonly diagnosed clinical manifestations of MFS. However, overlapping clinical manifestations with other aneurysmal disorders present a significant challenge in early and accurate diagnosis of MFS. While FBN1 mutations, abnormal transforming growth factor-β signaling and dysregulated matrix metalloproteinases have been implicated in MFS, clinically accepted risk-stratifying biomarkers have yet to be reliably identified. In this review, we summarize current consensus and recent insights in the understanding of MFS pathogenesis. Finally, we introduce the application of induced pluripotent stem cells (iPSCs) as cellular models for MFS and its potential as a novel platform into providing better appreciation of mechanisms underlying MFS diverse manifestations in the cardiovascular system. Highlights: Management of Marfan syndrome is complicated by overlapping disorders. Prognosis of Marfan syndrome is hampered by a scant understanding of the disease. Cellular modeling is promising in providing mechanistic insights into Marfan syndrome.